Diabetic foot muscle thickness and cross - sectional area diferences with neuropathy

Diabetes or diabetes mellitus is a chronic, progressive, incurable, lasting the whole of human life from its imposition, a disease accompanied by macrovascular (coronary heart disease, cerebral vascular, peripheral arterial disease) and Microvascular (retinopathy, nephropathy, neuropathy) complications (Frank et al., 2011). International Diabetes Federation, the data in the world today suffers 285 million people (Frank et al., 2011). Diabetic foot is a long-term complication of diabetes in developing neuropathy and peripheral artery disease (Hurley et al., 2013). Diabetic neuropathy is a complication of diabetes, which is often ending with amputation of foot muscle atrophy. Neuropathic process, the importance of assessing the degree of muscle atrophy. Thus, it is important to determine the degree of atrophy of the foot muscles to help assess neuropathic process and determine the appropriate timely therapy strategies (Wang et al. 2014). Severinsen and others (2007) suggest that ultrasound is a reliable technique for monitoring and controlling muscle atrophy diabetinėje foot. Hypothesis. We believe that the diabetic foot at neuropathy muscle thickness and cross-sectional area less than the diabetic foot without neuropahy and control group. The aim of research: to evaluate and compare the diabetic foot at neuropathy muscle thickness and cross-sectional area differences with diabetic footwithout neuropathy and the control group subjects. Work tasks: 1. Compare the control group subjects of the foot muscle thickness and cross-sectional area of the norms. 2. To evaluate and compare the diabetic foot without neuropathy muscle thickness and cross-sectional area results with the control group subjects. 3. To evaluate and compare the diabetic foot at neuropathy muscle thickness and cross-sectional area with the diabetic foot without neuropathy and control group subjects